Basic information
Biomarker: mPRγ
Biomarker subtype: gene
Clinical application: prognosis(favorable)
Histology type: endometrial carcinoma
Cohort characteristics
Region: Slovenia
Cohort age: 62.5±13.6
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 50 | EC | 50 |
Sample information
Sample type : tissue
Clinical method: Quantitative PCR
Disease information
Statictics: Mean (SD)
Cohort age: 62.5±13.6
Related information
Description: Membrane progesterone receptors γ has potential as prognostic biomarkers of endometrial cancer.
Approved symbol: PAQR5
Approved name: progestin and adipoQ receptor family member 5
Locus type: gene with protein product
HGNC ID: HGNC:29645
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:29645
Symbol status: Approved
Alias symbols: FLJ20190 MPRG
OMIM: 607781
Omim link: https://www.omim.org/entry/607781
NCBI name: 54852
NCBI link: https://www.ncbi.nlm.nih.gov/gene/54852
Summary: Predicted to enable signaling receptor activity. Predicted to be involved in oogenesis. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Expression: Biased expression in kidney (RPKM 13.9), adrenal (RPKM 5.4) and 9 other tissues
NCBI gene expression https://www.ncbi.nlm.nih.gov/gene/54852#gene-expression
PDB ID: Q9NXK6
PDB link: https://alphafold.ebi.ac.uk/entry/Q9NXK6
